Literature DB >> 21136030

Investigations on parotid gland recovery after IMRT in head and neck tumor patients.

Markus Stock1, Wolfgang Dörr, Carmen Stromberger, Ulrike Mock, Susanne Koizar, Richard Pötter, Dietmar Georg.   

Abstract

PURPOSE: in recent years, the role of intensity-modulated radiotherapy (IMRT) for head and neck irradiation has increased. The main motivation is sparing the parotid gland and reduction of xerostomia. Generally, relative parotid volumes have been evaluated for treatment outcome and planning constraints, neglecting that absolute parotid volumes can vary significantly. The aim of the present study was to investigate changes in parotid gland function and set this in relation to absolute volumes.
MATERIAL AND METHODS: 46 head and neck patients were treated by sparing at least the contralateral parotid gland. The mean dose to the contralateral gland was limited to 26 Gy. Parotid function was measured with scintigraphy before and at 3, 6, 9, and 12 months after radiotherapy. Gland recovery was correlated with absolute parotid gland volumes and mean dose. Finally the dose-effect relationship was investigated.
RESULTS: the dose-volume histograms (DVHs) for the ipsi- and contralateral glands were significantly different. A correlation between absolute volumes receiving certain doses and the function loss after 3, 6, 9, and 12 months was found. The most significant correlation was found for the absolute volume that received at least 40 Gy (aV40). ED50 values of 23-38 Gy were observed for more than 50% function loss and and 52-68 Gy afor more than 75% function loss.
CONCLUSION: the mean dose, aV40 or aV26, revealed similar correlations with the excretion rate and with recovery. Hence, also absolute volumes can be used for treatment planning. Longer recovery times show higher ED50 values indicating partial regeneration of gland functions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21136030     DOI: 10.1007/s00066-010-2157-7

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  32 in total

1.  Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer.

Authors:  A Eisbruch; R K Ten Haken; H M Kim; L H Marsh; J A Ship
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-10-01       Impact factor: 7.038

2.  CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines.

Authors:  Vincent Grégoire; Peter Levendag; Kian K Ang; Jacques Bernier; Marijel Braaksma; Volker Budach; Cliff Chao; Emmanuel Coche; Jay S Cooper; Guy Cosnard; Avraham Eisbruch; Samy El-Sayed; Bahman Emami; Cai Grau; Marc Hamoir; Nancy Lee; Philippe Maingon; Karin Muller; Hervé Reychler
Journal:  Radiother Oncol       Date:  2003-12       Impact factor: 6.280

Review 3.  Radiotherapy dose-volume effects on salivary gland function.

Authors:  Joseph O Deasy; Vitali Moiseenko; Lawrence Marks; K S Clifford Chao; Jiho Nam; Avraham Eisbruch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

4.  Inverse planning--a comparative intersystem and interpatient constraint study.

Authors:  Dietmar Georg; Bernhard Kroupa; Petra Georg; Peter Winkler; Joachim Bogner; Karin Dieckmann; Richard Pötter
Journal:  Strahlenther Onkol       Date:  2006-08       Impact factor: 3.621

5.  The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy.

Authors:  Yun Li; Jeremy M G Taylor; Randall K Ten Haken; Avraham Eisbruch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-12-04       Impact factor: 7.038

6.  Analysis of salivary flow and dose-volume modeling of complication incidence in patients with head-and-neck cancer receiving intensity-modulated radiotherapy.

Authors:  Simona Marzi; Giuseppe Iaccarino; Katia Pasciuti; Antonella Soriani; Marcello Benassi; Giorgio Arcangeli; Giuseppe Giovinazzo; Michaela Benassi; Laura Marucci
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-03-15       Impact factor: 7.038

Review 7.  Late effects of radiation therapy in the head and neck region.

Authors:  J S Cooper; K Fu; J Marks; S Silverman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-03-30       Impact factor: 7.038

8.  A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003.

Authors:  K K Fu; T F Pajak; A Trotti; C U Jones; S A Spencer; T L Phillips; A S Garden; J A Ridge; J S Cooper; K K Ang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-08-01       Impact factor: 7.038

9.  Longitudinal assessment of parotid function in patients receiving tomotherapy for head-and-neck cancer.

Authors:  Mia Voordeckers; Hendrik Everaert; Koen Tournel; Dirk Verellen; Ilan Baron; Gretel Van Esch; Chris Vanhove; Guy Storme
Journal:  Strahlenther Onkol       Date:  2008-08       Impact factor: 3.621

10.  Parotid-gland-sparing 3D conformal radiotherapy in patients with bilateral radiotherapy of the head and neck region--results in clinical practice.

Authors:  Jeremias Hey; Jürgen Setz; Reinhard Gerlach; Martin Janich; Simone Sehlleier; Hans-Günter Schaller; Christian R Gernhardt; Thomas Kuhnt
Journal:  Oral Oncol       Date:  2008-07-14       Impact factor: 5.337

View more
  16 in total

1.  Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN).

Authors:  Dirk Rades; Nina D Seibold; Maximilian P Gebhard; Frank Noack; Steven E Schild; Christoph Thorns
Journal:  Strahlenther Onkol       Date:  2011-09-19       Impact factor: 3.621

2.  Phase-specific cone beam computed tomography reduces reconstructed volume loss of moving phantom.

Authors:  H-L Chao; W-L Chen; C-C Hu; J-K Wu; C-J Wu; J C-H Cheng
Journal:  Strahlenther Onkol       Date:  2011-12-24       Impact factor: 3.621

3.  Critical discussion of evaluation parameters for inter-observer variability in target definition for radiation therapy.

Authors:  I Fotina; C Lütgendorf-Caucig; M Stock; R Pötter; D Georg
Journal:  Strahlenther Onkol       Date:  2012-01-27       Impact factor: 3.621

4.  Parotid gland-recovery after radiotherapy in the head and neck region--36 months follow-up of a prospective clinical study.

Authors:  Jeremias Hey; Juergen Setz; Reinhard Gerlach; Martin Janich; Guido Hildebrandt; Dirk Vordermark; Christian R Gernhardt; Thomas Kuhnt
Journal:  Radiat Oncol       Date:  2011-09-27       Impact factor: 3.481

5.  Pattern and predictors of volumetric change of parotid glands during intensity modulated radiotherapy.

Authors:  G Sanguineti; F Ricchetti; O Thomas; B Wu; T McNutt
Journal:  Br J Radiol       Date:  2013-09-12       Impact factor: 3.039

6.  Early changes of parotid density and volume predict modifications at the end of therapy and intensity of acute xerostomia.

Authors:  Maria Luisa Belli; Elisa Scalco; Giuseppe Sanguineti; Claudio Fiorino; Sara Broggi; Nicola Dinapoli; Francesco Ricchetti; Vincenzo Valentini; Giovanna Rizzo; Giovanni Mauro Cattaneo
Journal:  Strahlenther Onkol       Date:  2014-04-23       Impact factor: 3.621

7.  Practically acquired and modified cone-beam computed tomography images for accurate dose calculation in head and neck cancer.

Authors:  Chih-Chung Hu; Wen-Tao Huang; Chiao-Ling Tsai; Jian-Kuen Wu; Hsiao-Ling Chao; Guo-Ming Huang; Chun-Wei Wang; Chien-Jang Wu; Jason Chia-Hsien Cheng
Journal:  Strahlenther Onkol       Date:  2011-09-23       Impact factor: 3.621

8.  Three-dimensional patient setup errors at different treatment sites measured by the Tomotherapy megavoltage CT.

Authors:  S K Hui; E Lusczek; T DeFor; K Dusenbery; S Levitt
Journal:  Strahlenther Onkol       Date:  2012-03-09       Impact factor: 3.621

9.  Radio(chemo)therapy in the management of squamous cell carcinoma of cervical lymph nodes from an unknown primary site. A retrospective analysis.

Authors:  K Fakhrian; R Thamm; S Knapp; M Molls; S Pigorsch; B Haller; H Geinitz
Journal:  Strahlenther Onkol       Date:  2011-12-23       Impact factor: 3.621

10.  Time course of late rectal- and urinary bladder side effects after MRI-guided adaptive brachytherapy for cervical cancer.

Authors:  P Georg; A Boni; A Ghabuous; G Goldner; M P Schmid; D Georg; R Pötter; W Dörr
Journal:  Strahlenther Onkol       Date:  2013-05-25       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.